发明申请
US20070197588A1 Tetralone-based monoamine reuptake inhibitors 有权
基于四氢萘酮的单胺再摄取抑制剂

Tetralone-based monoamine reuptake inhibitors
摘要:
The invention relates to novel tetralone based amines and their use in the treatment of central nervous system (CNS) disorders, such as depression, attention deficit hyperactivity disorder (ADHD) and Parkinson's disease. The invention further relates to pharmaceutical compositions containing the compounds and compositions of the invention as well as methods of inhibiting reuptake of one or more monoamine, such as such as dopamine and norepinephrine, from the synaptic cleft, and methods of modulating one or more monoamine transporter.
公开/授权文献
信息查询
0/0